MSCDX
Price
$20.44
Change
-$0.08 (-0.39%)
Updated
Jul 31 closing price
Net Assets
592.58M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MSCDX vs NAESX

MSCDX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
MSCDX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCDX is a Buy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. MSCDX (593M). NAESX pays higher dividends than MSCDX: NAESX (1.10) vs MSCDX (0.47). MSCDX was incepted earlier than NAESX: MSCDX (22 years) vs NAESX (66 years). MSCDX (0.75) is less costly to investors than NAESX (0.17). MSCDX is a more actively managed with annual turnover of: 40.00 vs. NAESX (17.00). MSCDX (0) and NAESX (0) have matching initial minimum investment requirements. NAESX annual gain was more profitable for investors over the last year : 22.56 vs. MSCDX (14.92). NAESX return over 5 years is better than : 34.95 vs. MSCDX (9.09).
MSCDXNAESXMSCDX / NAESX
Total Expense Ratio0.750.17441%
Annual Report Gross Expense Ratio0.750.17441%
Fund Existence22 years66 years-
Gain YTD16.93414.563116%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets593M189B0%
Annual Yield % from dividends0.471.1043%
Returns for 1 year14.9222.5666%
Returns for 3 years19.5943.3045%
Returns for 5 years9.0934.9526%
Returns for 10 years55.54155.2836%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv